Japanese Pharmas Need To Get More Global
This article was originally published in The Pink Sheet Daily
Executive Summary
Japanese firms need to change strategy to become competitive with U.S., European firms, biotech exec says in interview with "The Pink Sheet" DAILY during the BioInvestor Forum in San Francisco.